Protocolo diagnóstico y terapéutico de las poliglobulias
- García Ramírez, P. 1
- Villafuerte Gutiérrez, P. 1
- 1 Servicio de Hematología y Hemoterapia, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, España
ISSN: 0304-5412
Année de publication: 2020
Serie: 13
Número: 21
Pages: 1224-1228
Type: Article
D'autres publications dans: Medicine: Programa de Formación Médica Continuada Acreditado
Objectifs de Développement Durable
Résumé
Polycythemia or erythrocytosis refers to an increase in hemoglobin and hematocrit concentration in peripheral blood. The erythopoietin, produced in 95% of renal cells, is in charge of erythropoiesis regulation due to hypoxia and is elevated in secondary erythrocytosis. The most important primary erythrocytosis is polycythemia vera, a chronic myeloproliferative neoplasm that produces erythrocytosis independently of erythropoietin due to a mutation in erythroid progenitor cells. A diagnosis is established based on an increase in hemoglobin above 16.5 g/dl in men and 16 g/dl in women. An etiological diagnosis is fundamental for an appropriate management of the patient.
Références bibliographiques
- Lee G, Arcasoy MO. The clinical and laboratory evaluation of the patient with erythrocytosis. Eur J Intern Med. 2015;26(5):297-302.
- Keohane C, McMullin MF, Harrison C. The diagnosis and mana-gement of erythrocytosis. BMJ. 2013;347:f6667.
- Swerdlow SH, Campo E, Harris N. WHO Classification of Tu-mours of Haematopoietic and Lymphoid Tissues, revised. 4th ed. Inter-national Agency for Research on Cancer (IARC), Lyon; 2017.Carpeta 08_PROT_MEDICINE_21 (1224-1228).indd 122817/11/20 13:31
- Arrizabalaga B. Eritrocitosis secundarias adquiridas. Eritrocitosis idiopática. Eritropatología. Barcelona: Ambos Marketing; 2017. p 501-13.
- Bento C, Magalhaes T, Ribeiro ML. Eritrocitosis congénita. Eritro-patología. Barcelona: Ambos Marketing; 2017; 515-27.
- McMullin MF. Investigation and Management of Erythrocytosis. Curr Hematol Malig Rep. 2016;11:342-7